Anthracimycin

Anthracimycin
Clinical data
ATC code	none;
Identifiers
PubChem CID	102496082;
ChemSpider	29272409;
Chemical and physical data
Formula	C25H32O4
Molar mass	396.527 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@@H]1/C=C\C=C\[C@H](OC(=O)[C@@H](C(=O)/C=C(/[C@H]2[C@@H]1C=C[C@@H]3[C@@H]2CC=C(C3)C)\O)C)C;
	InChI InChI=1S/C25H32O4/c1-15-9-11-21-19(13-15)10-12-20-16(2)7-5-6-8-17(3)29-25(28)18(4)22(26)14-23(27)24(20)21/h5-10,12,14,16-21,24,27H,11,13H2,1-4H3/b7-5-,8-6+,23-14-/t16-,17-,18-,19+,20-,21+,24+/m1/s1; Key:MHXKMAAKEHGISP-MROKOONJSA-N;

Anthracimycin is a polyketide antibiotic discovered in 2013. Anthracimycin is derived from marine actinobacteria. In preliminary laboratory research, it has shown activity against Bacillus anthracis,^[1] the bacteria that causes anthrax, and against methicillin-resistant Staphylococcus aureus (MRSA).^[2]

Clinical data

ATC code	none
Identifiers
PubChem CID	102496082
ChemSpider	29272409
Chemical and physical data
Formula	C₂₅H₃₂O₄
Molar mass	396.527 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES C[C@@H]1/C=C\C=C\[C@H](OC(=O)[C@@H](C(=O)/C=C(/[C@H]2[C@@H]1C=C[C@@H]3[C@@H]2CC=C(C3)C)\O)C)C
InChI InChI=1S/C25H32O4/c1-15-9-11-21-19(13-15)10-12-20-16(2)7-5-6-8-17(3)29-25(28)18(4)22(26)14-23(27)24(20)21/h5-10,12,14,16-21,24,27H,11,13H2,1-4H3/b7-5-,8-6+,23-14-/t16-,17-,18-,19+,20-,21+,24+/m1/s1 Key:MHXKMAAKEHGISP-MROKOONJSA-N